000 01741 a2200565 4500
005 20250517064216.0
264 0 _c20180309
008 201803s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/leu.2015.322
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHoster, E
245 0 0 _aTotal body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials.
_h[electronic resource]
260 _bLeukemia
_c06 2016
300 _a1428-30 p.
_bdigital
500 _aPublication Type: Comparative Study; Letter
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntimetabolites, Antineoplastic
_xadministration & dosage
650 0 4 _aChemoradiotherapy
650 0 4 _aCytarabine
_xadministration & dosage
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHumans
650 0 4 _aLymphoma, Mantle-Cell
_xtherapy
650 0 4 _aMiddle Aged
650 0 4 _aStem Cell Transplantation
650 0 4 _aWhole-Body Irradiation
700 1 _aGeisler, C H
700 1 _aDoorduijn, J
700 1 _avan der Holt, B
700 1 _aWalewski, J
700 1 _aBloehdorn, J
700 1 _aRibrag, V
700 1 _aSalles, G
700 1 _aHallek, M
700 1 _aPott, C
700 1 _aSzymczyk, M
700 1 _aKolstad, A
700 1 _aLaurell, A
700 1 _aRäty, R
700 1 _aJerkeman, M
700 1 _aVan't Veer, M
700 1 _aKluin-Nelemans, J C
700 1 _aKlapper, W
700 1 _aUnterhalt, M
700 1 _aDreyling, M
700 1 _aHermine, O
773 0 _tLeukemia
_gvol. 30
_gno. 6
_gp. 1428-30
856 4 0 _uhttps://doi.org/10.1038/leu.2015.322
_zAvailable from publisher's website
999 _c25476955
_d25476955